GT-induced suppressor cells and the transfer of their suppressive activity to normal syngeneic recipients can be effectively prevented by the administration of CC.
Materials and Methods
Animals. BALB/c mice were purchased from the same suppliers and maintained under the conditions described in the preceding paper (1) .
Antigens and Immunization. The TNP-KLH used in this study was the same as that described previously (1) . The hapten-carrier was conjugated to Sepharose 2-B (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) using the method described by Feldmann et al. (19) . The synthetic random copolymer, GT, with an average tool wt of 133,000, as well as the terpolymer of L-glutamic acid~°-L-alanine~°-L-tyrosine l° (GAT), tool wt 35,000, were obtained from Miles Laboratories Inc., Miles Research Products, Elkhart, Ind. MBSA was purchased from Worthington Biochemical Corp., Freehold, N. J. The GT-MBSA complex was prepared by the dropwise addition of MBSA (5 mg/ml) while stirring, to a solution of GT (1 mg]ml). Ai~r a 20-min interval during which maximum flocculation and aggregation occurred, the precipitate of GT-MBSA was washed three times in saline. For immunization, mice were injected intraperitoneally with 10 #g of GT as GT-MBSA in complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.). CC (Sigma Chemical Co., St. Louis, MO.) was freshly dissolved in physiological saline and administered intraperitoneally to animals at a dose of 1 mg/kg body weight.
Cell Transfers. BALB/c mice used as cell donors were injected intraperitoneally with Maalox, 100 #g GT in Maalox, or 100 #g GT in Maalox and 1.0 mg CC/kg. 3 days later, mice were sacrificed and their spleens were removed. Single cell suspensions were prepared, washed three times in Hanks' balanced salt solution, and 20 × l0 s lymphoid cells were adoptively transferred intravenously into normal syngeneic recipients. Mice were then immunized with GT-MBSA immediately after transfer.
Hemolytic Plaque Assay. The TNP-specific PFC response of immune animals was assessed as described previously (1) . The PFC response to GT-MBSA was assayed on sheep erythrocytes (SRBC) coupled with the cress-reacting polymer GAT, GAT-SRBC (20) . GT-specific plaques were determined by subtracting the number of PFC remaining after inhibition by a suitable dilution of GAT from the number of plaques detected on GAT-SRBC in the absence of the specific inhibitor (21) .
Results

CC Enhances the PFC Response of Normal and Nude Mice to TNP-KLH-
Sepharose. Although TNP-KLH is a thymus-dependent antigen, Feldmann and his colleagues have demonstrated that the conjugation of TNP-KLH to Sepharose (TKS) renders it thymus-independent (19). We performed experiments to test the effectiveness of CC in enhancing the antibody response to TKS in intact animals and in nude mice where T-cell regulation is absent. It can be seen from Fig. 1 that the simultaneous injection of CC with TKS into normal mice enhanced their hapten-specific PFC response. On the other hand, the administration of CC to congenitally athymic nude mice failed to increase their response (Table I) .
CC Abrogates GT-Induced Suppression of the PFC Response to GT-MBSA. It has been established that preinjection of the copolymer GT suppresses the GT-specific PFC response of certain inbred mouse strains, e.g. BALB/c mice, to a challenge of the immunogenic GT-MBSA antigen (21) . GT-induced suppression results from the stimulation of specific suppressor T cells (5, 17) . We adopted this system to test the effect of CC on the generation of GT-stimulated suppressor cells. First, we examined the effectiveness of CC in blocking GT from inducing nonresponsiveness to GT-MBSA in BALB/c animals. It can be seen from Table II that prior injection of GT effectively suppressed the GTspecific PFC responses of the injected animals in group II to a subsequent challenge with GT-MBSA. On the other hand, animals in group III, preinjected with GT as well as CC, developed a PFC response to GT-MBSA no different from that of control animals in group I.
Results of experiments described above strongly imply that CC may abolish the GT-induced suppression by inactivating the suppressor T cells. If this implication were correct, one would predict that the administration of CC to GT-primed donors should prevent the transfer of suppressor activity to normal syngeneic ~ecipients. It can be seen from Table III It could be argued that CC induces an elevated antibody response by its direct effect on B cells. Hence, we tested its action on congenitally athymic mice to a T-independent antigen, TKS. Our results indicate that CC did not enhance antibody formation in homozygous nude (nu/nu) mice where T-cell regulation is absent (Table I ). In contrast, the hapten-specific PFC response of intact animals to TKS can be enhanced by CC (Fig. 1) . Although it has been shown by Feldmann et al. (19) that helper T cells and macrophages are not required to elicit a hapten-specific response to TKS, the magnitude of the response might still be under the control of regulatory T cells, e.g. suppressor cells. The effectiveness of CC in elevating the antibody response to TKS in intact animals where T-cell regulation is present, and the failure of the drug to enhance the response to the same T-independent antigen in T-cell-deficient mice strongly imply that under our experimental conditions, one of the target cells acted upon by CC is a regulatory T cell. Our observation is analogous to the report by Baker et al. (22, 23 ) that anti-lymphocyte serum enhanced the response to type III pneumococcal polysaccharide, a T-independent antigen, in intact animals but not in T-cell-deficient nude animals.
Although results up to this point suggested that CC acts on suppressor cells, direct evidence to support the view was lacking. To demonstrate that CC in fact inactivates suppressor cells, we used a well-established system in which specific suppressor T cells are induced by the injection of GT in BALB/c animals (5, 21) . It is clear from these experiments that the simultaneous injection of CC with GT effectively prevented the induction of GT-specific suppression of PFC response to GT-MBSA (Table II) . Furthermore, the administration of CC to GTprimed donor animals abolished the cell-mediated transfer of suppressive activity to normal syngeneic recipients challenged with GT-MBSA (Table III) . This observation provided direct evidence that CC inactivated or eliminated suppressor T cells. It is noteworthy that GT-specific suppression in BALB/c mice can also be abolished by pretreatment with cyclophosphamide (18) .
The selective action of CC on the inactivation of suppressor cells or their precursors appears to be a matter of the appropriate time of its administration. Recent studies by Eardley and Sercarz (10) demonstrated that a wave of suppression occurs as the initial event immediately following immunization in a hapten-carrier system, and that carrier-specific suppressor cells are generated as early as 24 h after the injection of antigen. Moreover, such suppression required cell division (7) . Hence, the finding that simultaneous administration of CC with an antigen consistently enhances the antibody response (1) , and that CC is capable of inactivating suppressor cell activities (Tables II and III) , strongly substantiate the view that CC interferes with the generation of the initial wave of suppression, and this in turn leads to a subsequent augmentation of the antibody response.
Of course, the demonstration that CC acts on suppressor cells does not exclude the possibility that it may also be acting on other cell types. For example, we cannot rule out as yet its possible effect on macrophages, and its possible action on helper T cells in the enhancing process. A possible contribu-tion by macrophages in enhancing the antibody response may be partly the result of increased efficiency of macrophages in processing the antigen. However, CC has been shown to inhibit phagocytosis (24) (25) (26) and to interfere with certain metabolic processes in particle ingestion (24, 27) . Thus, these observations on the effect of CC upon neutrophil and macrophage functions suggest that the administration of CC with an antigen probably would not significantly facilitate macrophages in antigen processing. It also appears unlikely to us that any interference with the generation of helper T cells by an anti-mitotic dose of CC would facilitate rather than impair helper function. In view of our current finding that the early administration of CC in relation to antigen injection is a prerequisite for successful enhancement of tl/e antibody response, we tend to favor the alternative possibility that suppressor cells or their precursors, which appear early after antigenic stimulation, are its principal targets.
Summary
The simultaneous administration of colchicine (CC) with a T-independent antigen, e.g. 2,4,6-trinitrophenyl-keyhole limpet hemocyanin-Sepharose, to intact animals effectively enhanced their hapten-specific plaque-forming cell (PFC) response. However, in congenitally athymic nude mice in which T-cell regulation was absent, CC was ineffective in producing enhancement. These observations suggest that the target cell acted upon by CC is most likely thymus-derived. Furthermore, the injection of CC with the co-polymer of Lglutamic acidS°-L-tyrosine 5° (GT) abolished GT-specific suppression of the PFC response to GT-methylated bovine serum albumin. Spleen cells from CC-treated and GT-primed hosts could no longer transfer suppressive activity to normal recipients. These results provide evidence that CC is capable of inactivating or eliminating suppressor cells or their precursors. Thus, CC-induced enhancement of the antibody response may be explained, at least in part, by its antimitotic, and hence lethal effect on dividing suppressor T cells.
